Neonatal jaundice Hyperbilirubinemia Severe neonatal hyperbilirubinemia Neonatal jaundice Hyperbilirubinemia Newborn Smartphone Screening
Conditions
Interventions
Clinically well neonates with gestational age 35 to 42 weeks and age 1 to 14 days who require bilirubin assessment for neonatal jaundice. All participants will undergo standard bilirubin measurement a
Screening
Neonates requiring bilirubin assessment
Sponsors
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
1 Days to 14 Days
Inclusion criteria
Inclusion criteria: 1. Clinically well neonates at GA 35-42 weeks, aged 1-14 days 2. Requiring TSB and/or TcB for evaluation of neonatal jaundice 3. Informed consent obtained
Exclusion criteria
Exclusion criteria: 1. Recent phototherapy or exchange transfusion within 24 hours 2. Abnormal skin lesions at the measurement site 3. Neonatal cholestasis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agreement and Correlation between Smartphone-based bilirubin measurement and Total serum bilirubin At time of bilirubin measurement Bland Altman analysis and correlation coefficient between smartphone based bilirubin measurement and total serum bilirubin | — |
Secondary
| Measure | Time frame |
|---|---|
| Screening performance of smartphone-based bilirubin measurement for clinically significant hyperbilirubinemia At time of bilirubin measurement - Sensitivity, Specificity, Positive predictive value and Negative predictive value for detecting clinically significant hyperbilirubinemia,Agreement and Correlation between Smartphone-based bilirubin measurement and Transcutaneous bilirubin At time of bilirubin measurement Bland Altman analysis and correlation coefficient between smartphone based bilirubin and transcutaneous bilirubin | — |
Countries
Thailand
Contacts
Public ContactVissuta Koyekaewphring
Mahidol University/ Ramathibodi Hospital
Outcome results
None listed